Induced Pluripotent Stem Cells Market Size, Share and Growth Forecast for 2025 – 2032

Table of Content

1. Executive Summary
   1. Global Induced Pluripotent Stem Cells Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 – 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors – Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Diseases Epidemiology
   3. In-Vivo Modelling for Neurological Disorder
   4. Pipeline Assessment
   5. Regulatory Landscape
   6. Value Chain Analysis
   7. Key Deals and Mergers
   8. PESTLE Analysis
   9. Porter’s Five Force Analysis
4. Global Induced Pluripotent Stem Cells Market Outlook
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2023
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2024–2032
   3. Global Induced Pluripotent Stem Cells Market Outlook: Cell Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Cell Type, 2019-2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Cell Type, 2024–2032
         1. Hepatocytes
         2. Fibroblasts
         3. Keratinocytes
         4. Neurons
         5. Others
      4. Market Attractiveness Analysis: Cell Type
   4. Global Induced Pluripotent Stem Cells Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024–2032
         1. Drug Development
         2. Regenerative Medicine
         3. Toxicity Testing
      4. Market Attractiveness Analysis: Application
   5. Global Induced Pluripotent Stem Cells Market Outlook: End-user
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2024–2032
         1. Academic and Research Institutes
         2. Biotechnology Companies
      4. Market Attractiveness Analysis: End-user
5. Global Induced Pluripotent Stem Cells Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024–2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Induced Pluripotent Stem Cells Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
      1. By Country
      2. By Service
      3. By Application
      4. By End-user
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024–2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Cell Type, 2024–2032
      1. Hepatocytes
      2. Fibroblasts
      3. Keratinocytes
      4. Neurons
      5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024–2032
      1. Drug Development
      2. Regenerative Medicine
      3. Toxicity Testing
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2024–2032
      1. Academic and Research Institutes
      2. Biotechnology Companies
   7. Market Attractiveness Analysis
7. Europe Induced Pluripotent Stem Cells Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
      1. By Country
      2. By Service
      3. By Application
      4. By End-user
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024–2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Cell Type, 2024–2032
      1. Hepatocytes
      2. Fibroblasts
      3. Keratinocytes
      4. Neurons
      5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024–2032
      1. Drug Development
      2. Regenerative Medicine
      3. Toxicity Testing
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2024–2032
      1. Academic and Research Institutes
      2. Biotechnology Companies
   7. Market Attractiveness Analysis
8. East Asia Induced Pluripotent Stem Cells Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
      1. By Country
      2. By Service
      3. By Application
      4. By End-user
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024–2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Cell Type, 2024–2032
      1. Hepatocytes
      2. Fibroblasts
      3. Keratinocytes
      4. Neurons
      5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024–2032
      1. Drug Development
      2. Regenerative Medicine
      3. Toxicity Testing
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2024–2032
      1. Academic and Research Institutes
      2. Biotechnology Companies
   7. Market Attractiveness Analysis
9. South Asia & Oceania Induced Pluripotent Stem Cells Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
      1. By Country
      2. By Service
      3. By Application
      4. By End-user
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024–2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Cell Type, 2024–2032
      1. Hepatocytes
      2. Fibroblasts
      3. Keratinocytes
      4. Neurons
      5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024–2032
      1. Drug Development
      2. Regenerative Medicine
      3. Toxicity Testing
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2024–2032
      1. Academic and Research Institutes
      2. Biotechnology Companies
   7. Market Attractiveness Analysis
10. Latin America Induced Pluripotent Stem Cells Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
       1. By Country
       2. By Service
       3. By Application
       4. By End-user
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024–2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Cell Type, 2024–2032
       1. Hepatocytes
       2. Fibroblasts
       3. Keratinocytes
       4. Neurons
       5. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024–2032
       1. Drug Development
       2. Regenerative Medicine
       3. Toxicity Testing
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2024–2032
       1. Academic and Research Institutes
       2. Biotechnology Companies
    7. Market Attractiveness Analysis
11. Middle East & Africa Induced Pluripotent Stem Cells Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
       1. By Country
       2. By Service
       3. By Application
       4. By End-user
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024–2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Cell Type, 2024–2032
       1. Hepatocytes
       2. Fibroblasts
       3. Keratinocytes
       4. Neurons
       5. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024–2032
       1. Drug Development
       2. Regenerative Medicine
       3. Toxicity Testing
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2024–2032
       1. Academic and Research Institutes
       2. Biotechnology Companies
    7. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping by Market
       2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       1. Lonza Group AG
          1. Overview
          2. Segments and Cell Types
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Axol Bioscience Ltd. 
       3. Evotec 
       4. Hitachi, Ltd. 
       5. ViaCyte, Inc. 
       6. Merck KGaA 
       7. Takara Bio Inc.
       8. REPROCELLS, Inc. 
       9. Fate Therapeutics 
       10. Thermo Fisher Scientific, Inc. 
       11. FUJIFILM Cellular Dynamics, Inc. 
       12. Applied StemCells, Inc.
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations